Friday 6 November 2026
Export MET’s income statement to Excel — free account
MetLife, Inc.
MetLife, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $77.1 billion, up 8.59% from fiscal 2024.
- Revenue
- +18.2%
- EPS
- +200.8%
- Free cash flow
- +1.87%
- Total debt
- −28.1%
Quarter to September 2026, against a year earlier
99.79
3.10
−3.01%
Follow MET
Alert me
| Sep '26 From the 10-Q filed 6 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
12.28 | 16.21 | 13.71 | 16.80 |
+8 more quarters Free account |
P/S ratio |
0.72 | 0.68 | 0.59 | 0.69 | |
P/FCF ratio |
4.27 | 3.49 | 2.97 | 3.09 | |
P/Operating CF |
29.90 | 24.40 | 17.16 | 7.46 | |
P/B ratio |
2.66 | 1.96 | 1.67 | 1.84 | |
Price to Tangible BV |
4.61 | 2.99 | 2.56 | 2.77 | |
EV/Sales |
— | 0.70 | 0.56 | 0.65 | |
EV/EBITDA |
— | 11.34 | 9.08 | 10.75 | |
EV/Operating CF |
— | 3.55 | 2.82 | 2.93 | |
EV/FCF |
— | 3.55 | 2.82 | 2.93 | |
Quick Ratio |
0.00 | 0.15 | 0.15 | 0.15 | |
Current Ratio |
— | 0.15 | 0.15 | 0.15 | |
Net Debt/EBITDA |
0.00 | 0.80 | (1.59) | (2.42) | |
Debt/Assets |
1.95% | 2.65% | 2.73% | 2.59% | |
Debt/Equity |
0.65 | 0.73 | 0.74 | 0.67 | |
Asset Turnover |
0.11 | 0.11 | 0.11 | 0.11 | |
Operating CF/Net income |
0.85 | 3.16 | 2.36 | 9.10 | |
Capex/Depreciation |
— | — | — | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(10.90) | (12.16) | (13.93) | (12.21) | |
Graham Number |
78.23 | 71.21 | 70.10 | 67.34 | |
Earnings Yield |
8.15% | 6.17% | 7.30% | 5.95% | |
Free Cash Flow Yield |
23.40% | 28.61% | 33.65% | 32.37% | |
Revenue per Share |
32.32 | 29.81 | 29.25 | 35.60 | |
Operating CF per Share |
3.15 | 3.47 | 4.12 | 10.58 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
3.15 | 3.47 | 4.12 | 10.58 | |
Cash per Share |
31.16 | 30.04 | 34.80 | 32.94 | |
Shareholders Equity per Share |
35.46 | 43.17 | 42.32 | 42.88 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
35.46 | 43.17 | 42.32 | 42.88 | |
Free Cash Flow |
2,000.00 | 2,228.00 | 2,687.00 | 7,076.00 | |
Working Capital |
— | (409,993.00) | (401,837.00) | (401,303.00) | |
Net Current Asset Value |
(721,894.00) | (661,269.00) | (642,139.00) | (644,735.00) | |
EV/EBIT |
— | 11.34 | 9.08 | 10.75 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
8.98 | 11.17 | 9.58 | 11.33 | |
| Other line items | |||||
Average Receivables |
46,265.50 | 41,559.00 | 41,189.50 | 39,887.50 | |
Average Payables |
— | 225,616.50 | 225,160.50 | 223,599.00 | |
Average Assets |
732,167.00 | 730,921.00 | 715,763.50 | 711,311.50 | |
Average Common Equity |
25,855.00 | 27,834.00 | 27,675.00 | 28,191.50 |
Columns are period end dates · fundamentals updated 6 Nov 2026